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Abstract BACterial Hosts for production of Bioac-
tive phenolics from bERRY fruits (BacHBerry) was a
3-year project funded by the Seventh Framework
Programme (FP7) of the European Union that ran
between November 2013 and October 2016. The
overall aim of the project was to establish a sustainable
and economically-feasible strategy for the production
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of novel high-value phenolic compounds isolated from
berry fruits using bacterial platforms. The project
aimed at covering all stages of the discovery and pre-
commercialization process, including berry collec-
tion, screening and characterization of their bioactive
components, identification and functional characteri-
zation of the corresponding biosynthetic pathways,
and construction of Gram-positive bacterial cell
factories producing phenolic compounds. Further
activities included optimization of polyphenol extrac-
tion methods from bacterial cultures, scale-up of
production by fermentation up to pilot scale, as well as
societal and economic analyses of the processes. This
review article summarizes some of the key findings
obtained throughout the duration of the project.
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Abbreviations
4CL 4-coumaryl-CoA ligase
AD Alzheimer’s disease
ANS Anthocyanidin synthase
ALS Amyotrophic lateral sclerosis;
anthocyanidin synthase
ANR Anthocyanidin reductase
C30H p-coumaroyl shikimate/quinate 30-
hydroxylase
C4H Cinnamate 4-hydroxylase
CBD Convention on biological diversity
CaN Calcineurin
CDRE Calcineurin-dependent responsive element
CHI Chalcone isomerase
CHR Chalcone reductase
CHS Chalcone synthase
CPR Cytochrome-P450 reductase
CVs Column volumes
CYP Cytochromes P450
DFR Dihydroflavonol 4-reductase
F3H Flavanone 3-hydroxylase
F30H Flavonoid 30-hydroxylase
F3050H Flavonoid 30-50-hydroxylase
FLS Flavonol synthase
FNS Flavone synthase
FP7 European Commission’s the Seventh
Framework programme
GFP Green fluorescent protein
GRAS Generally regarded as safe
HCT Hydroxycinnamoyl-CoA shikimate/quinate
hydroxycinnamoyltransferase
HD Huntington’s disease
HPLC High-performance liquid chromatography
LAR Leucoanthocyanidin reductase
B. Avila  P. Ban˜ados
Facultad De Agronomı´a e Ingenierı´a Forestal, Pontificia
Universidad Cato´lica de Chile, Av. Vicun˜a Mackenna
Ote, 4860 Macul, Chile
D. Barbay  M. Benkoulouche  H. Heider 
M. Naesby  C. Rousseau
Evolva, Duggingerstrasse 23, 4053 Reinach, Switzerland
J.-E. Bassard  B. Hamberger
Department of Plant and Environmental Science,
University of Copenhagen, 1871 Frederiksberg, Denmark
M. Bott  N. Kallscheuer  J. Marienhagen  M. Vogt
Forschungszentrum Ju¨lich GmbH, Institut fu¨r Bio- und
Geowissenschaften, IBG-1: Biotechnologie, Wilhelm-
Johnen-Straße, 52428 Ju¨lich, Germany
A. Braga  N. Faria  P. Ferreira  J. Oliveira 
I. Rocha  A. R. Silva
Biotempo, Avepark – Edif. Spinpark, Zona Industrial da
Gandra, Barco, 4805-017 Guimara˜es, Portugal
C. Chanforan  V. Mazurek  F. T. Okkels  O. Simon
Chr. Hansen Natural Colors A/S, Agern Alle 24,
2970 Hørsholm, Denmark
R. S. Costa  M. Doostmohammadi  A. Fernandes 
A. Hartmann  A. Verı´ssimo  A. Vila-Santa  S. Vinga
IDMEC, Instituto Superior Te´cnico, Universidade de
Lisboa, Av. Rovisco Pais 1, 1049-001 Lisbon, Portugal
R. Brennan  A. Foito  S. Freitag  L. Shepherd 
D. Stewart
The James Hutton Institute, Invergowrie, DD2 5DA,
Dundee, Scotland, UK
O. P. Kuipers  A. Solopova
Groningen Biomolecular Sciences and Biotechnology
Institute, Department of Molecular Genetics, University
of Groningen, Linnaeusborg, Nijenborgh 7,
9747 AG Groningen, The Netherlands
D. Breitel  N. Love  C. Martin  V. Thole 
M. Trick  P. Vain
John Innes Centre, Norwich Research Park,
NR4 7UH Norwich, UK
Phytochem Rev
123
LC-
MS
Liquid-chromatography mass-spectrometry
NDs Neurodegenerative diseases
NFAT Nuclear Factor of Activated T-cells
NFjB Nuclear Factor jB
NP-
ABS
The Nagoya protocol on access to genetic
resources and the fair and equitable sharing
of benefits arising from their utilization
OMT O-methyltransferase
PAL Phenylalanine ammonia-lyase
PCA Principal component analysis
PD Parkinson’s disease
PLS Partial least squares
RNA-
seq
RNA sequencing technology
STS Stilbene synthase
SVR Support vector regression
TAL Tyrosine ammonia-lyase
UFGT Flavonoid 3-O-glucosyltransferase
Introduction
BacHBerry (BACterial Hosts for production of Bioac-
tive phenolics from bERRY fruits, www.bachberry.
eu) has received funding from the European Com-
mission’s Seventh Framework Programme (FP7)
under the theme KBBE.2013.3.1-01: ‘‘Plant High
Value Products—from discovery to final product’’
with the goal of bringing together experts from the
fields of plant biology, industrial biotechnology, ana-
lytical chemistry, and social sciences in order to
assemble and validate a complete pipeline for dis-
covery and microbial production of novel phenolic
compounds of plant origin. The consortium consisted
of twelve academic groups, five small and medium
sized enterprises and one large enterprise from eleven
different countries, namely Austria, Chile, China,
Denmark, France, Germany, The Netherlands, Portu-
gal, Russia, Switzerland and the United Kingdom. The
diversity of partners has allowed access to a variety of
expertise and to plant material that had not been
characterized extensively.
Polyphenols as a source of bioactive molecules
Historically, plants have been not only important
sources of nutrients and energy in the human diet but
also have provided the fundamentals of traditional and
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modern medicine. The Plantae kingdom has been
estimated to produce more than 200,000 different
chemical compounds (Weckwerth 2003), including
compounds with proven and potential medical appli-
cations. This is reflected in the high number of
pharmaceutical products based on, or derived from,
plant natural products, such as aspirin, morphine,
quinine, paclitaxel and artemisinin (Cragg and New-
man 2013). Among the different classes of specialized
(i.e. secondary) metabolites, phenylpropanoids stand
out due to their diversity and ubiquity in the plant
kingdom. Fleshy fruits, a rich source of bioactive
components, such as ascorbate (vitamin C), terpenoids
and polyphenols, are considered to have one the
highest antioxidant capacity of commonly eaten foods
(Halvorsen et al. 2006). Polyphenol content and
composition can vary substantially between fleshy-
fruit varieties (Carvalho et al. 2013; Miladinovic´ et al.
2014; Kula et al. 2016), different cultivation condi-
tions (Josuttis et al. 2013; Vagiri et al. 2013; Mazur
et al. 2014), harvest times and as a result of different
post-harvest factors (Ka˚rlund et al. 2014; Stavang
et al. 2015), but particularly between species (Moyer
et al. 2001; McDougall et al. 2008; Ruiz et al. 2010;
Marhuenda et al. 2016). Furthermore, plant polyphe-
nols are increasingly being associated with putative
bioactivities offering protection against several car-
diovascular (Goszcz et al. 2015) and neurological
diseases (Figueira et al. 2017).
The hydroxystilbenes are a group of polyphenols
with a C6–C2–C6 skeleton with two or more hydroxyl
groups, where a central carbon–carbon double bond is
conjugated with two phenolic moieties (Quideau et al.
2011; Kasiotis et al. 2013). The most well-known
representative of this group is resveratrol (trans-3,5,40-
hydroxystilbene; Fig. 1a). The compound has gained
increasing attention with the discovery of the ‘‘French
paradox’’, an observation that despite a diet with
relatively high amounts of saturated fats, French
people suffer a relatively low incidence of mortality
from coronary heart disease (Renaud and de Lorgeril
1992; Catalgol et al. 2012). Like other polyphenols,
stilbenes can be further decorated by O-methylation
(e.g. resulting in 3-methoxy-resveratrol, or pinostil-
bene, and 3,50-dimethoxy-resveratrol, or pterostil-
bene), acylation (hydrangenic acid) or by
glycosylation (e.g. piceid and resveratroloside; Kim
et al. 2002; Becker et al. 2003; Zhang et al. 2009;
Wang et al. 2015).
The flavonoids are one of the largest families of
phenolic compounds. Flavonoids are characterized by
their basic skeleton composed of three rings (Ghosh
and Scheepens 2009), including two benzene rings (A
& B) and one heterocyclic ring (C; Fig. 1b). So far,
over 5000 naturally occurring flavonoids have been
characterized from various plants and they have been
classified into six subgroups, including anthocyanidins
(e.g. cyanidin and delphinidin); flavan-3-ols (e.g.
catechin and epicatechin); flavonols (e.g. quercetin
and kaempferol); flavones (e.g. luteonin and api-
genin); isoflavones (e.g. genistein and daidzein), and
flavanones (e.g. hesperetin and naringenin).
Within each subgroup, considerable variation can
exist when it comes to phenolic composition of
different fruits, and in particular of berries. Antho-
cyanin composition provides an excellent example of
this diversity: the red–orange color of strawberries is
due to the presence of pelargonidin-type anthocyanins
in the flesh and skin, whereas the deep purple-black
color of blackcurrants is due to the accumulation of
high amounts of delphinidin and cyanidin-type antho-
cyanins in the skin.
Anthocyanidins are flavonoids, which are charac-
terized by a hydroxyl group in position 3 and a C-ring
with a positively-charged oxonium ion (Fig. 1b).
Anthocyanins are water-soluble glycosides of antho-
cyanidins, in which sugars, consisting of one or more
hexoses, are linked to the 3-hydroxyl group of the
Fig. 1 a The molecular
structure of the stilbene
trans-resveratrol. b Basic
flavonoid structure. Rx are
positions where decorating
groups (e.g. hydroxyl, acyl,
glycosyl, etc.), which
differentiate the compounds
and alter their chemical
properties, could be attached
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pyrylium ring (Heldt and Piechulla 2011). These
compounds are responsible for the orange/red-to-blue
coloration observed in some plants. The most common
anthocyanidins include cyanidin (red), delphinidin
(bluish-purple), malvinidin (reddish-purple),
pelargonidin (orange-red), peonidin (pink) and petu-
nidin (purple). The distribution of anthocyanidins can
vary greatly among different berry species (Table 1).
Flavonoid compounds frequently are decorated
with sugar moieties, sugar-acyl moieties (Giusti and
Wrolstad 2003) and can be associated with other
flavonoids. The patterns of decoration differ greatly
amongst species (see supplementary Tables S1 and
S2).
Flavonoids are far more prevalent and diverse in
berry species than in other common fruits and
vegetables. High flavonol contents are observed in
cranberry, lingonberry and blackcurrant (Ha¨kkinen
et al. 1999), anthocyanins are the most abundant
polyphenol pigments (2–5 g kg-1 fresh weight) in
berries (Ma¨a¨tta¨ et al. 2001), and many simple phenolic
acids are abundant in a wide range of berry species
(Herrmann and Nagel 1989). Additionally, berries
constitute one the most important dietary sources of
ellagitannins, such as sanguiin H6 and lambertianin C
(To¨rro¨nen 2009; Landete 2011), as well as condensed
tannins, such as the proanthocyanidins (Rasmussen
et al. 2005; Hellstro¨m et al. 2009). Stilbenes, in
contrast, are not that widespread in berries: resveratrol
shows highest abundance in grapes (up to
20–30 mg kg-1 fresh weight), but small amounts of
resveratrol, pterostilbene and piceatannol have been
also detected in blueberry, cowberry, cranberry,
deerberry and lingonberry (Jeandet et al. 1991;
Paredes-Lo´pez et al. 2010; Manganaris et al. 2014).
It is clear that soft-fruit species contain a staggering
diversity of distinct polyphenol derivatives whose
potential is yet to be harnessed.
The market for polyphenolic compounds has seen
substantial growth over the past few years, and is
expected to exceed 850 million USD by 2018 (Aranaz
et al. 2016). The major factors contributing to this trend
are the growing consumer awareness regarding the
benefits of polyphenol consumption and the increasing
use of polyphenol-containing extracts in food, bever-
age, and cosmetics products particularly in Asia (Jain
and Ramawat 2013; Aranaz et al. 2016; Grand View
Research Inc. 2016). The increase in demand also
requires efficient and eco-friendly production pro-
cesses, to improve on current manufacturing practices
that mostly rely on extraction from various plant
sources (e.g. roots, leaves or fruits) via complex
Table 1 Anthocyanidin structures (aglycone form) found in different berry species
Type Pelargonidin Cyanidin Delphinidin Peonidin Petunidin Malvinidin
Structure
Molecular formula C15H11O5
? C15H11O6
? C15H11O7
? C16H13O6
? C16H13O7
? C17H15O7
?
Fragariaa ? ? – – – –
Ribesa ? ? ? – ? –
Rubuaa ? ? – – – –
Vacciniuma – ? ? ? ? ?
Vitisa – ? ? ? ? ?
Lonicerab,e ? ? ? ? – ?
Lyciumc – – ? – ? ?
Berberisd – ? ? ? ? ?
Ugnid – ? – ? – –
Aristoteliaf – ? ? – – –
The presence of a compound is noted with ? whereas the absence is noted with
aPhenol explorer database (http://phenol-explorer.eu), b (Chaovanalikit et al. 2004), c (Zheng et al. 2011), d (Ruiz et al. 2010), e
(Wang et al. 2016b), f (Fredes et al. 2014)
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downstream processing (Wang et al. 2016a). The
BacHBerry consortium decided to address these chal-
lenges and set the following objectives: (1) to system-
atically analyze the phenolic contents in the large berry
germplasm collections available from consortium
members, (2) to establish a publicly-available database
of transcriptomic and metabolic data obtained from
berry bioprospecting within, as well as outside of the
project, (3) to discover novel bioactivities in berry
extracts against a range of human pathologies, such as
Alzheimer’s disease and Amyotrophic Lateral Sclero-
sis (ALS), by high-throughput screening with subse-
quent identification of functional biomolecules, (4) to
identify the corresponding biosynthetic genes and
perform functional characterization of the respective
gene products, (5) to assay a selection of the biosyn-
thetic genes for functionality in Gram-positive bacte-
rial hosts and use those to construct bacterial cell
factories for phenolic production, (6) to improve the
production efficiency further by introducing modifica-
tions to the host metabolic networks predicted via
rational design or computational tools developed
within the project, (7) to design and optimize cost-
effective food-grade methods for extraction of pheno-
lic compounds from bacterial fermentation broth, and
(8) to optimize fermentation conditions and subse-
quently upscale the production to pilot plant levels.
The project commenced with the selection, sam-
pling and whole-metabolite profiling of berries. In
order to explore the potential of the phytochemical
diversity present in different berry species, we under-
took an untargeted characterization of a wide collec-
tion of berries from different species/cultivars utilizing
metabolomics-based methods to aid the selection of
candidate berry extracts for bioactivity screening.
Phytochemical diversity in sampled berries
Although significant advances have been made in
characterizing the polyphenolic complement of ber-
ries, particularly in the context of cultivated species
and genotypes, there is limited literature available
regarding the phytochemical composition of wild and
underutilized species/cultivars. Indeed, wild berries
are commonly reported as particularly rich in diverse
phenolic compounds, often as a result of phenolic-
associated astringency having been bred out of
cultivated species (Ha¨kkinen et al. 1999). The
phenolic diversity of individual berries has been
highlighted in many publications (Ma¨a¨tta¨ et al. 2003;
Zadernowski et al. 2005; Milivojevic´ et al. 2011), but
studies that capture this broad diversity systematically
are limited. In BacHBerry, we aimed not only to
address this knowledge gap but also to go beyond the
state-of-the-art by combining analyses of phenolic
diversity with functional testing of berry extracts. The
genera targeted in this study included Rubus, Ribes,
Vaccinium, Lonicera, Lycium, Aristotelia, Berberis
and Ugni collected from different locations in the
world including Chile, China, Portugal, Russia and
United Kingdom (see Supplementary Table S3).
Berry extract metabolite profiling
Fruit samples from a total of 112 species/genotypes
were collected, extracted, and subsequently subjected
to liquid-chromatography mass-spectrometry (LC–
MS) metabolomic analysis (see details in Supplemen-
tary Materials S1). An untargeted method was used to
generate a total of 1890 mass spectral features (1506
and 384 in positive and negative modes, respectively),
which were integrated to generate the dataset used for
statistical analysis. Principal component analysis
(PCA) was used as a multivariate statistical analysis
tool to identify those species, which had the most
distinct phytochemical profiles (Fig. 2a, b).
Using the four principal components it was possible
to select the species/genotypes, which represented the
broadest phenolic diversity (Table 2). In addition to
selecting the outlier groups of species, it was also
decided to include a small subset of samples (two
Rubus idaeus genotypes), which did not separate from
the majority of samples in the first principal compo-
nents. This provided samples with phenolic profiles
distinct from the outlier samples and standards for
comparison between uncultivated/underutilized spe-
cies and commonly grown species; in essence a
commercial control. The fruits from the selected
species (Table 2) were extracted and tested for
bioactivity in baker’s yeast (Saccharomyces cere-
visiae) models for pathological processes associated
with several chronic disorders.
Berry extract bioactivity screening
Evidence for the protective role of polyphenols against
chronic diseases has increased over the past 20 years
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Fig. 2 Principal component analysis (PCA) plots of the full
dataset without reference material and blanks. Each dot
represents the profile of one sample aliquot whereas lines
delimit groups of samples that cluster together. a PCA plots of
the full dataset without reference material and blanks in positive
mode. Components (Scr) 1 and 2 explain 9.79 and 7.59% of the
variation respectively. b PCA plots of the full dataset without
reference material and blanks in negative mode. Components
(Scr) 1 and 2 explain 13.20 and 10.30% of the variation
respectively
Table 2 Selected species for bioactivity testing according to the phytochemical diversity
Species Variety/line Species Variety/line
Aristotelia chilensis (Molina)Stuntz – Rubus armeniacus Focke Himalayan Giant
Berberis buxfolia Lam. – Rubus occidentalis L. Huron
Lonicera caerulea L. S322-23 Rubus loganobaccus L.H.Bailey Sunberry
Lycium chinense Mill. – Rubus loganobaccus L.H.Bailey Tayberry
Ribes grossularia L. 9294 Rubus bartonii Newton Ashton Cross
Ribes grossularoides Maxim. H1-12-1 Rubus fruticosus L. agg. Fantasia
Ribes nevadense Kellog – Rubus brigantinus Samp. –
Ribes spp. 644217 Rubus genevierii Boreau. –
Ribes spp. 1126 Rubus henriquesii Samp. –
Ribes spp. 2292-1 Rubus hochstetterorum Seub. –
Ribes spp. Muravushka Rubus sampaioanus Sudre ex Samp. –
Ribes spp. – Rubus vagabundus Samp. –
Ribes petraeum Wulf. R2-1-2 Rubus idaeus L. Octavia
Ribes x saundersii Jancz. XB4 Rubus idaeus L. Prestige
Ribes bethmontii Jancz. XW6 Ugni molinae Turcz. Red Pearl
Ribes rubrum L. S11-3-36 Vaccinium uliginosum L. –
Rubus spp. B14 Vaccinium vitis-idaea L. –
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(Figueira et al. 2017; Goszcz et al. 2015). Neurode-
generative diseases (NDs) represent a group of chronic
neurological conditions affecting millions of people
worldwide, among which are the Alzheimer’s Disease
(AD), the Parkinson’s Disease (PD), the Huntington’s
Disease (HD), and Amyotrophic Lateral Sclerosis
(ALS). All these diseases have in common the
aggregation and deposition of protein aggregates,
namely of amyloid b42 (Ab42; O’Brien and Wong
2011), aSynuclenin (aSyn; Shults 2006), huntingtin
(HTT; Miller-Fleming et al. 2008) and FUsed in
Sarcoma (FUS; Kwiatkowski et al. 2009; Vance et al.
2009), which represent the pathological hallmarks of
AD, PD, HD and ALS, respectively. In addition,
chronic activation of innate immune responses is a
process closely associated with neurodegeneration. Its
modulation is driven by persistent activation of key
transcription factors, such as the Nuclear Factor of
Activated T-cells (NFAT) and Nuclear Factor jB
(NFjB), which upregulate pro-inflammatory
responses creating a positive feedback loop further
amplifying initial stimuli. It has been argued that
disruption of this loop may represent an important
strategy to mitigate the progression of NDs. The
pleiotropic effects of polyphenols have been shown to
interfere with aggregation-driven neurodegeneration
as well as to attenuate chronic inflammatory processes,
thereby improving health of cellular and animal
models (Figueira et al. 2017). Consequently, polyphe-
nol-based therapies represent an underexplored strat-
egy to minimize the huge social and economic impact
of NDs.
The high degree of evolutionary conservation of
fundamental biological processes among eukaryotes
has established baker’s yeast as a validated model
organism to decipher the intricacies of human
pathologies, particularly NDs, to identify molecular
targets amenable to therapeutic intervention as well as
lead molecules with health-promoting potential (Krit-
zer et al. 2009; Su et al. 2010; Tardiff et al. 2012;
Menezes et al. 2015). BacHBerry aimed at identifying
phenolic bioactives from harnessing the diversity of
phenolics in selected berry germplasm from culti-
vated, wild and underutilized species of berries. The
yeast-based screening platform for bioactivity identi-
fication comprised a set of genetically–modified S.
cerevisiae strains expressing Green Fluorescent Pro-
tein (GFP) fused with Ab42 (Bharadwaj et al. 2010),
aSyn (Outeiro and Lindquist 2003), HTT (Krobitsch
and Lindquist 2000) and FUS (Ju et al. 2011) under the
control of a galactose-inducible promoter (Fig. 3a).
Upon activation of expression, these proteins start
forming aggregates, which consequently has a nega-
tive impact on cellular growth and results in lower
GFP fluorescence levels. In case an extract possesses
bioactivity against one of the diseases, addition of the
extract to the activated yeast cells reduces growth
inhibition in the corresponding model. These yeast
strains accelerated the identification of phenolic
compounds with health-promoting attributes among
the most chemically diverse samples identified by the
metabolomic analysis (Table 2). For information on
the procedures used during the screening see Supple-
mentary Materials S1.
An illustrative example of how bioactivities for AD
were identified is given in Fig. 4a. Upon shift of cells
to galactose medium to induce expression of GFP-
Ab42, yeast growth was impaired in comparison to the
control strain indicating GFP-Ab42 proteotoxicity.
The treatment with polyphenol-enriched extracts of
Lycium chinense significantly recovered growth of
these cells revealing its protective role via modulation
of Ab42 toxicity. The bioactivities for PD, HD and
ALS were screened using a similar approach, in cells
expressing the respective disease proteins.
In addition, we have also used a yeast-based model
for inflammatory signaling that is based on a Crz1
reporter-strain (Prescott et al. 2012; Garcia et al. 2016;
Fig. 3b). Crz1 is a yeast orthologue of NFAT, which is
an important modulator of inflammation in humans
that is known to be involved in development of
multiple disorders, such as the inflammatory bowel
disease or the rheumatoid arthritis (Pan et al. 2013).
Both Crz1 and NFAT are known to be activated by a
serine/threonine protein phosphatase calcineurin
(CaN) in a Ca2?-dependent manner (Rusnak and
Mertz 2000; Bodvard et al. 2013). The utilized
reporter strain encodes the b-galactosidase gene (lacZ)
under the control of a promoter bearing Crz1-binding
sites, the Calcineurin-Dependent Responsive Element
(CDRE), allowing the assessment of Crz1 activation
through the measurement of b-galactosidase activity
using chromogenic substrates (Garcia et al. 2016).
Given the evolutionary conservation of NFAT and
Crz1 activation mechanisms, in combination with the
conserved activity of the immunosuppressant FK506
both in yeast and in humans, the yeast Ca2?/CaN/Crz1
reporter assay represents a reliable tool to identify
Phytochem Rev
123
bioactives with potential to attenuate NFAT-mediated
inflammatory responses. The potential of Lycium
chinense polyphenol-enriched extracts to attenuate
inflammation is shown in Fig. 4b, exemplifying the
approach used in BacHBerry to filter for potential anti-
inflammatory activities. The activation of Crz1 by
MnCl2, mimicking NFAT activation, led to high b-
galactosidase activity and cell treatment with FK506
and Lycium chinense extract strongly reduced the b-
galactosidase levels revealing its ability to modulate
Crz1, and potentially NFAT, activation.
These examples illustrate the strategy used in the
BacHBerry project to search for bioactive compounds
interfering with pathological processes of NDs and
inflammation. The yeast-based screening platform
also included strains allowing the identification of
metabolites with potential application for type II
diabetes, hematological diseases and cancer (unpub-
lished results).
Bioassay-guided fractionation compound
discovery and candidate compound validation
This method of discovering new bioactive natural
products ultimately depends on the availability of
biological material and preparative- or semi-prepara-
tive-scale analytical methods with the capability of
resolving mixtures of different classes of compounds
typically present in berry extracts (Pauli et al. 2012).
Semi-preparative chromatography was used to frac-
tionate selected berry extracts with potential bioactive
properties using a hybrid approach of bioassay-guided
fractionation procedure (Yang et al. 2001; Weller
2012; Tayarani-Najaran et al. 2013) and screening of
pure compounds (Watts et al. 2010). Bioassay-guided
fractionation typically involves the following steps:
assessment of bioactivity, extraction of the biological
material with different solvents and testing of bioac-
tivity. Once bioactivity of an extract has been
Fig. 3 Schematic representation of yeast models. a Yeast
models of neurodegenerative diseases. Humanized yeast strains
encoding chimeric fusions of disease genes with GFP (green
fluorescent protein) under the control of a galactose-inducible
(GAL1) promoter. Expression of Ab42, aSyn (SNCA gene),
FUS and HTTpQ103 leads to the formation of toxic aggregates,
recapitulating the pathological processes of Alzheimer’s disease
(AD), Parkinson’s disease (PD), Amyotrophic lateral sclerosis
(ALS), and Huntington’s disease (HD), respectively. b Yeast
model of Crz1 (NFAT orthologue) activation. Crz1 is activated
by the serine/threonine protein phosphatase calcineurin (com-
posed by CnA and CnB subunits). The reporter strain encodes
the lacZ gene under the control of a promoter containing Crz1-
binding sites, allowing the assessment of Crz1 activation
through the measurement of b-galactosidase activity
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validated, the extract gets subjected to an iterative
process of sub-fractionation/bioactivity testing until
pure bioactive natural products are obtained for
structural characterization. This approach benefits
from exclusion of extracts that do not have bioactivity.
However, this procedure requires extensive use of
biological material and expensive materials and may
result in the isolation of already-known natural
products (Duarte et al. 2012). Another disadvantage
is that the approach is based on the assumption that
bioactivity is conferred by a pure compound, although
this method can also be used for identification of
bioactivities conferred by a cumulative interactions of
several polyphenols. Alternatively, pure-compound
screening relies on an initial isolation and structural
elucidation of the individual compounds present in the
biological extract followed by bioassay screening.
This strategy allows the researcher to focus solely on
novel compounds, without re-discovering compounds
with well-annotated bioactivity. However, it may also
lead to the identification of novel compounds with no
bioactivity (Duarte et al. 2012). The second method
misses any synergistic interactions affecting bioactiv-
ities of berry phenolics.
The limited amount of biological material available
restricted the number of iterations of fractionation and
re-testing of fraction bioactivity possible for typical
bioassay-guided fractionation approaches. As
described previously, berry extracts typically com-
prise a relatively diverse and large pool of metabolites
that surpass by far the throughput capability of the
bioactivity assays used in this study. To overcome
these challenges, a hybrid approach was adopted
which consisted of several steps: (1) assessment of
potential bioactivity present in extracts (as described
above), (2) fractionation of bioactive extracts (see
Supplementary Materials S1), (3) assessment of
potential bioactivity present in fractions, (4) mass-
spectrometry-based chemical characterization of
bioactive fractions, (5) bioactivity testing of pure
candidate compounds (Fig. 5). Although this
approach shared some of the limitations of the other
approaches, it did allow for the exclusion of non-
bioactive biological extracts or fractions and focused
on the identification novel compounds with potential
(a) (b)
Fig. 4 Identification of bioactivities in the berry germplasm.
a Strategy used for the discovery of bioactive compounds for
Alzheimer’s disease. BY4741_erg6 recombinant yeast cells
expressing GFP-Ab42 were grown in SD galactose medium and
cell viability was assessed by growth curves for 24 h in cells
challenged or unchallenged with Lycium chinense polyphenol
extracts. Cells containing the empty vector were used as
controls. The areas under the curve (AUC) were integrated using
the Origin software (OriginLab, Northampton, MA). Values
represent the mean ± standard error of mean (SEM) of at least
three biological replicates. b Strategy used for the discovery of
bioactive compounds with anti-inflammatory potential. BY4741
yeast cells encoding CDREpromoter-lacZ were treated or not with
Lycium chinense polyphenol extracts and induced with 1.8 mM
MnCl2. Crz1 activation was assessed by monitoring b-galac-
tosidase activity using ortho-nitrophenyl-b-galactoside
(ONPG). The immunosuppressant FK506, a well-known
inhibitor of calcineurin (Dumont 2000) was used as a positive
control. The values represent the mean ± SEM of at least three
biological replicates, *p\ 0.05, **p\ 0.01, ***p\ 0.001
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bioactivities with limited requirement for biological
material.
Following fractionation of the most promising
berry extracts from the first round of screening using
the yeast-based platform, isolated fractions were re-
analyzed in order to detect bioactive fractions. Sub-
sequently, metabolomic analyses were used for the
identification of the individual compounds in each of
the bioactive fractions. By utilizing this approach, a set
of candidate compounds was defined and re-tested as
pure compounds in the yeast-based platform, with
further bioactivity validation in the mammalian cell
models. Following the BacHBerry pipeline, this
information then served as starting point for the
engineering of the synthetic pathway for biosynthesis
of one of the validated compounds in food-grade
bacteria and its subsequent production in small-scale
fermenters. The final step of the pipeline, namely re-
confirmation of bioactivity of microbially-produced
compounds extracted from fermentation broth in both
yeast and mammalian cell models, is currently
underway.
Identification of metabolic pathways
and regulators involved in phenolic production
The next step within the BacHBerry pipeline involved
the identification of the biosynthetic genes and
pathways corresponding to the newly discovered
bioactives, in order to establish production of these
compounds in bacterial hosts. In plants, the biosyn-
thesis of polyphenols occurs via the phenylpropanoid
pathway, where the aromatic amino acid L-phenylala-
nine serves as a precursor. Depending on the enzyme
combination, several compounds can be produced in
bacteria, including cinnamic acid derivatives, lignin
subunits, lignans, phenylpropenes and coumarins, all
sharing a basic C6–C3 skeleton (Vogt 2010). Further-
more, the phenylpropanoid backbone can be extended
with up to three acetyl-units derived from malonyl-
CoA by chalcone synthase (CHS) or stilbene synthase
(STS), polyketide synthases which generate various
polyketides, such as flavonoids and stilbenes. The core
pathways of phenolic biosynthesis are very well
understood, with common enzymes, such as, pheny-
lalanine ammonia lyase (PAL), cinnamate 4-hydrox-
ylase (C4H), p-coumaroyl CoA ligase (4CL),
hydroxycinnamoyl-CoA shikimate/quinate hydrox-
ycinnamoyltransferase (HCT), p-coumaroyl shiki-
mate/quinate 30-hydroxylase (C30H), stilbene
synthase and chalcone synthase, found in many plant
species (Fig. 6).
Phenolic chemodiversity in berries, as in other
plants, derives from a variety of decorations to the
backbone of phenolic structures that include hydrox-
ylations, O-methylations, prenylations, aryl migra-
tions, glycosylations, acylations and polymerizations.
Fig. 5 Yeast as a discovery
platform of therapeutic
compounds. Iterative bio-
guided fractionation of
complex mixtures allows the
discovery of small
molecules improving cell
growth, by rescue of protein
aggregates toxicity, or
inhibiting inflammatory
processes. High-throughput
formats aligned with
chemical identification by
LC–MS approaches
accelerate the identification
of candidate compounds
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For example, anthocyanins are glycosylated on 3-OH
positions of the C-ring (Fig. 1) and many harbor
additional glycosyl groups (for example 50-O-glyco-
sylation and 30-O-glycosylation), methoxy groups
(petunidin and malvinidin), or hydroxyl groups [which
differentiate pelargonidin, cyanidin and delphinidin
(Fig. 6; Table 1)]. These decorations may affect the
bioavailability, bioactivity and stability of polyphe-
nolic compounds. It is therefore essential to develop a
greater knowledge of the decorating enzymes specific
to berry bioactives, such as those differentially
decorating anthocyanins, flavonols, stilbenes, or con-
densed tannins. Many genes encoding enzymes
involved in flavonol and anthocyanin decoration have
already been characterized not only in planta, but also
heterologously in microorganisms, such as Escher-
ichia coli and S. cerevisiae (Tohge et al. 2005; Luo
et al. 2007; Pandey et al. 2016; Wang et al. 2016a).
Berry bioactives identified within the project had
special decorations, and those where the genes
encoding the decorating activities had not been
previously identified, required further research. In a
recent work, the transcriptome of the commercial
blueberry (Vaccinium corymbosum) was studied using
RNA sequencing technology (RNA-seq) in order to
discover putative genes related to antioxidant produc-
tion using next-generation sequencing (NGS; Li et al.
2012). Similarly, we aimed to identify decorating
enzymes and regulators of the biosynthetic pathways
of berry bioactives by obtaining transcriptome
sequences of target species at different stages of fruit
development. This information was used to construct a
database of transcriptome sequences for a broad range
of berry species, especially those identified as target
species containing the promising bioactive molecules.
In addition, the overall production of polyphenols is
regulated by a range of transcription factors and these
were also investigated within the BacHBerry project,
with the objective of identifying markers for breeding
enhanced levels of phenolic bioactives using the
diverse germplasm in selected berry species.
Firstly, a library of reference sequences consisting
of plant gene sequences encoding enzymes of the core
phenolic biosynthetic pathways, which was subse-
quently used for BLAST searches of berry transcrip-
tomes, was compiled. This library included well-
known and experimentally validated anthocyanin,
flavonol, stilbene and catechin biosynthetic enzymes
from a wide range of plant species. Next, 13
germplasms spanning eight genera, seven families
and seven orders were selected for RNA-seq of berry
transcriptomes. Sequencing of selected berries at
different stages of maturation was also conducted.
The data have provided significant resources not only
for understanding phenolic biosynthesis in berries, but
also for investigating commonalities in genes
expressed in berries (Table 3).
Multi-layer comparisons of the metabolomics and
transcriptomics data of developmental stages, and
targeted, as well as, non-targeted searches of candidate
transcripts were performed to elucidate genes
involved in specific phenolics biosynthetic pathways.
Analyses of expression of these genes from different
developmental stages of selected berry species were
performed with the expVIP tool (Borrill et al. 2016).
These data were used to search for genes encoding
putative decorating enzymes based on the list of
molecules of potential interest as bioactives and
having special decorations in target berry species.
Candidates were identified mostly by searching for
homologues of well-characterized plant genes. This
was carried out with the help of MassBlast, a software
developed within the BacHBerry project (https://
github.com/averissimo/mass-blast; Verı´ssimo et al.
2017). We annotated all major enzyme families,
including cytochromes P450 (CYP), 2-oxoglutarate-
dependent dioxygenases (2-OGDs), UDP-glycosyl-
transferases (UGTs), BAHD acyltransferases, and O-
methyltransferases (OMTs), in all 13 selected berry
germplasms. Average counts per transcriptome are
presented in Table 4. We also detected candidate
transcript(s) for 60–80% of the known biochemical
steps of the phenylpropanoid pathway, representing
between 109 and 180 candidates per transcriptome.
Approximately 40% of these candidates identified
from the transcriptomes were full-length sequences.
bFig. 6 Polyphenol biosynthetic pathway in plants (modified
from Falcone Ferreyra et al. 2012). PAL phenylalanine
ammonia-lyase, C4H cinnamate 4-hydroxylase, 4CL 4-coumar-
oyl-CoA ligase, CHS chalcone synthase, CHI chalcone iso-
merase, F3H flavanone 3-hydroxylase, F3050H flavonoid 30-50-
hydroxylase, DFR dihydroflavonol 4-reductase, ANS antho-
cyanidin synthase, ANR anthocyanidin reductase, UFGT
flavonoid 3-O-glucosyltransferase, LAR leucoanthocyanidin
reductase, FNS flavone synthase, FLS flavonol synthase, STS
stilbene synthase. P450 enzymes are highlighted in red
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Furthermore, biochemical activities of some of
enzymes encoded by the candidate genes were tested.
We also looked for transcripts encoding regulators
of phenolic biosynthesis. Since the R2R3-MYB gene
family operates extensively in controlling phenyl-
propanoid metabolism in plants (Stracke et al. 2001;
Hartmann et al. 2005), initial searches were focused on
identifying MYB-genes that were strongly expressed
in berries. However, members of the bHLH and bZIP
families of transcription factors were also identified in
the berry RNA-seq databases since they may also play
roles in regulating accumulation of phenolic bioac-
tives (Hartmann et al. 2005). These data could be
particularly useful in breeding programs for selection
of plants with improved bioactive contents. The
presence of genes encoding putative transporters of
phenolic compounds was also examined. Excretion of
target compounds produced by bacterial hosts into the
culture medium via such transporters would simplify
extraction procedures, and may also be necessary in
case of any toxic effects of these molecules in bacteria.
One transporter is currently being characterized
functionally.
Gram-positive bacteria as cell factories
for the efficient production of berry high-value
phenolics
While the search for novel bioactives was under way, a
set of well-characterized biosynthetic pathway was
used for establishing a platform for production of
phenolic compounds in Gram-positive bacteria. Two
major criteria were used for the selection of host
organisms for this task: (1) they had to be robust, well-
studied organisms with a long-standing history of
Table 3 Transcriptome
resources for berries
developed on BacHBerry
Species Plant material Total number of raw reads
Aristotelia sp. Ripe berries 397,707,372
Berberis sp. Ripe berries 444,362,698
Corema sp. Leaf 353,604,932
Lonicera sp. Ripe berries 397,214,254
Ribes sp.1 Ripe berries 336,479,242
Ribes sp.2 Ripe berries 393,665,630
Rubus sp.1 Berries (3 stages) 1,040,224,680
Rubus sp.2 Berries (3 stages) 1,064,858,518
Rubus sp.3 Ripe berries 505,754,030
Rubus sp.4 Ripe berries 390,608,452
Ugni sp. Ripe berries 405,024,920
Vaccinium sp.1 Ripe berries 373,159,882
Vaccinium sp.2 Ripe berries 375,778,718
Table 4 Statistics on five major enzyme families representing conserved biochemical steps of the phenylpropanoid pathway
Enzyme families Candidates per transcriptome (min–max)
Conserved phenylpropanoid pathway enzymes 109–180
CYPs 100–177
UGTs 70–145
2-OGDs 32–88
O-methyltransferases 8–51
Acyltransferases 23–36
Candidates displayed more than 70% sequence coverage to reference query sequences. This work led to the creation of a large dataset
of candidates used for pathway elucidation and reconstitution in bacterial hosts
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industrial use and (2) the bacteria must have a
generally regarded as safe (GRAS) status and/or be
recognized as food-grade. Two industrially-important
bacteria, namely Lactococcus lactis and Corynebac-
terium glutamicum, appeared as attractive candidates
for the sustainable production of value-added food and
pharmaceutical compounds (Lahtinen et al. 2011;
Jojima et al. 2013). Both L. lactis and C. glutamicum
are used worldwide in numerous industrial processes,
which consequently led to significant amount of
research work dedicated towards improving our
knowledge of their physiology and genetics. These
efforts have resulted in development of large tool-
boxes for (heterologous) gene expression and intro-
duction of genetic modifications in these bacteria
(Burkovski 2008; Pontes et al. 2011; Gaspar et al.
2013). Furthermore, high-throughput methodologies
for transcriptome, proteome and metabolome analysis,
and genome-scale metabolic models are available for
these species (Kro¨mer et al. 2004; Oliveira et al. 2005;
Shinfuku et al. 2009; Gaspar et al. 2013). Combined
with their general robustness, ease of handling and the
GRAS status, both L. lactis and C. glutamicum have a
strong potential for becoming platform organisms for
production of polyphenolic compounds.
It should also be noted that during the earlier stages
of the project, E. coli was also exploited as a platform
for reconstruction of polyphenol biosynthetic path-
ways. E. coli has a long history of use in research on
microbial-based production of various value-added
chemicals. Moreover, it is one of the best studied
organisms, easy to handle, and a much larger set of
genetic tools is available for this organism compared
to other bacteria (Yu et al. 2011; Dobson et al. 2012;
Chen et al. 2013). Furthermore, E. coli has been
previously used for heterologous production of
polyphenolic compounds (Pandey et al. 2016; Wang
et al. 2016a).
Lactococcus lactis
Lactococcus lactis is a Gram-positive bacterium from
the order of Lactobacillales that has been widely used
in the food industry for the manufacturing of cheese,
buttermilk and other dairy products. It is a low G ? C
aerotolerant bacterium with a relatively small genome
and simple sugar metabolism: utilization occurs via
glycolysis (Embden–Meyerhof–Parnas pathway) with
lactic acid being the major end-product (Gaspar et al.
2013). Its ability to ferment various carbohydrates,
such as hexoses, pentoses and, in some strains, even
complex carbohydrates of plant origin, as well as its
high alcohol, acid and stress tolerance makes this
bacterium suitable for the harsh environments com-
monly found under industrial production conditions.
Lactococcus lactis strains have been engineered to
produce multiple commodity chemicals (e.g. 2,3-
butanediol and butanol), as well as food additives,
including sweeteners (e.g. mannitol and xylitol),
flavorings (e.g. acetaldehyde and diacetyl), and vita-
mins. Furthermore, production of plant secondary
metabolites, namely isoprenoids and stilbenes, has
been demonstrated in this organism (Neves et al. 2005;
Katz et al. 2011; Gaspar et al. 2013; Song et al. 2014).
In addition, L. lactis is well known as an excellent host
for the expression of both prokaryotic and eukaryotic
proteins, and has been consequently used for devel-
opment of live vaccine (Kunji et al. 2005; Herna´ndez
et al. 2007; Frelet-Barrand et al. 2010; Pontes et al.
2011).
As depicted in Fig. 6, in plants the biosynthesis of
the core intermediate of the phenylpropanoid pathway,
p-coumaric acid, begins from L-phenylalanine and
occurs in two steps: a deamination reaction catalyzed
by phenylalanine ammonia-lyase (PAL) and a hydrox-
ylation reaction catalyzed by cinnamate 4-hydroxy-
lase (C4H). The latter enzyme belongs to the CYP
family that is often challenging to express in active
form in prokaryotic systems (Dvora and Koffas 2013).
However, in some bacteria and fungi there exists an
alternative pathway where L-tyrosine is converted
directly into p-coumaric acid via the action of tyrosine
ammonia-lyase (TAL), hence bypassing the C4H step
(Fig. 6). As a first step towards establishing a platform
strain for the production of polyphenols in L. lactis, in
collaboration with Nielsen and coworkers, we identi-
fied several novel TAL enzymes that specifically
produce high levels of p-coumaric acid from L-
tyrosine (Jendresen et al. 2015).
To test the potential of L. lactis to produce more
complex phenolic compounds, we introduced a path-
way for the biosynthesis of resveratrol. The introduced
pathway consisted of three enzymes: TAL, 4CL (4-
coumaroyl-CoA ligase, which converts p-coumaric
acid to p-coumaroyl-CoA), and STS (stilbene syn-
thase, which catalyzes the condensation of p-coumar-
oyl-CoA and three molecules of malonyl-CoA to yield
trans-resveratrol, Fig. 6). The corresponding genes
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were placed on the high copy number vector pNZ8048
under the control of the nisin-inducible promoter PnisA.
This promoter is a part of a tightly-controlled
inducible gene expression system which is based on
the auto-regulatory mechanism controlling the pro-
duction of the bacteriocin nisin (Kuipers et al.
1993, 1998). The producer L. lactis strain contains a
chromosomally-integrated two-component system
NisRK allowing induction of its target promoters by
addition of sub-inhibitory concentrations of the bac-
teriocin nisin to the exponentially-growing cell culture
(Linares et al. 2010). Upon cultivation of the producer
strain in a chemically defined medium, production of
trans-resveratrol was detected in the order of several
mg l-1. When TAL was replaced with a promiscuous
PAL/TAL enzyme (MacDonald and D’Cunha 2007),
additional production of small amounts of pinosylvin
(trans-3,5-dihydroxystilbene) from L-phenylalanine
was observed. Furthermore, production of methylated
variants of trans-resveratrol was also achieved (un-
published results). Obtained titers for trans-resveratrol
are comparable to those obtained in an early work on
trans-resveratrol production in both E. coli and yeast
(Beekwilder et al. 2006; Choi et al. 2011). Current
research efforts focus on improving the production
efficiency through metabolic engineering of the cen-
tral carbon metabolism for increased precursor supply.
Anthocyanins (glycosylated anthocyanidins) are
another group of phenolic phytochemicals. In addition
to their antioxidant properties, anthocyanins are
valuable for their colors, which range from orange to
blue (Falcone Ferreyra et al. 2012). They are of
particular interest for the food industry as natural
alternatives to replace synthetic dyes. Anthocyanins
are synthesized from flavanones by flavanone 3-hy-
droxylase (F3H), which adds a hydroxyl group to the
C3 position. Resulting dihydroflavonols are further
processed by dihydroflavonol 4-reductase (DFR),
which catalyzes reduction of the carbonyl group of
the C4 position to form leucoanthocyanidins, which in
turn are converted to anthocyanidins via the action of
anthocyanidin synthase (ANS). Anthocyanidins are
further stabilized through a C3-glycosylation reaction
usually catalyzed by UDP-glucose:flavonoid 3-O-
glucosyltransferase (UFGT) to form the anthocyanidin
3-O-glucosides (Falcone Ferreyra et al. 2012; Fig. 6).
In order to reconstruct the anthocyanin production
pathway in L. lactis, native genes and genes codon-
optimized for L. lactis from various plant species
coding for F3H, DFR, ANS and UFGT were placed
under control of the nisin-inducible promoter PnisA on
a high copy-number vector or were integrated into the
chromosome of L. lactis. Each protein was tagged with
an N- or C- terminal strep-tag, and Western blots were
performed to detect the heterologous proteins in cell-
free extract of L. lactis. Activity of each enzyme was
probed in vitro and in vivo and the reaction products
were analyzed using high performance liquid chro-
matography (HPLC). Production of various types of
cyanidin-derived anthocyanidins and anthocyanins by
the engineered L. lactis strains was detected, further
demonstrating the potential of this lactic acid bac-
terium as a production host for plant-derived bioactive
compounds for food applications (unpublished
results). To our knowledge, this is the first report of
using lactic acid bacteria for the production of
complex phenolic compounds.
Malonyl-CoA is a rate-limiting precursor in the
biosynthesis of various phenolic compounds in bac-
teria (Xu et al. 2011; Bhan et al. 2013). Under
physiological conditions, L. lactis cells use malonyl-
CoA as a substrate in the chain elongation step of the
fatty acid biosynthesis. FapR of Bacillus subtilis is a
transcriptional repressor that directly senses the intra-
cellular pool of malonyl-CoA. A metabolic biosensor
based on the interaction of malonyl-CoA with FapR
was previously designed in Escherichia coli (Xu et al.
2013). As a part of the efforts to enhance polyphenol
production, a transcriptional biosensor for malonyl-
CoA was constructed for the use in C. glutamicum but
also proved to be fully functional in L. lactis and could
therefore be used for screening of variants with an
enhanced malonyl-CoA pool (unpublished results).
Among other activities that were pursued in the
early stages of the project, we also tried to express
plant CYPs in L. lactis, as many steps of the
polyphenol biosynthetic pathway are catalyzed by
these heme-bound monooxygenases. Functional
expression of genes encoding membrane-anchored
CYPs in prokaryotes is known to be notoriously
difficult, and is limited by problems associated with
the differences in intracellular localization (natively to
the plant endoplasmatic reticulum), membrane com-
position, protein folding, and cofactor utilization. The
latter element became especially crucial when
attempting to express these proteins in L. lactis,
because this, normally anaerobic, bacterium does not
have the ability to synthetize heme, despite
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undergoing a metabolic shift to respiration when
supplemented with an exogenous source of heme and
being capable of regulating heme homeostasis (Ped-
ersen et al. 2012).
We focused our efforts on CYP79A1 from Sorghum
bicolor as it is a well-characterized CYP involved in
dhurrin biosynthesis (Bak et al. 2000), and has been
previously successfully produced in E. coli (Vazquez-
Albacete et al. 2016). As a testbed for the expression of
this CYP we have used the Waldo platform (Waldo
et al. 1999) that was previously instrumental in
producing functional CYP79A1 in E. coli. Briefly,
the platform is based on a fusion of the membrane
protein with a GFP folding reporter at the C terminus:
the fused GFP is designed to act as a fluorescent
reporter only when the membrane protein is properly
folded and its C terminus is oriented towards the
cytoplasm.
We detected CYP79A1-GFP by both fluorescence
measurements of the L. lactis culture and in-fluores-
cence protein gels, but were not able to detect activity
of the CYP in our in vitro tests. Purified membrane
protein fractions from cell cultures grown both
aerobically (with hemin supplementation) and anaer-
obically (with addition of hemin after purification of
membrane proteins) did not show any product forma-
tion in our TLC-based assay (Blomstedt et al. 2012).
These results suggested that CYP79A1 was probably
misfolded in L. lactis, although we did not perform any
follow-up experiments to confirm this hypothesis. The
topic was not pursued any further because any CYP
active in the biosynthetic pathways for the selected
model compounds could be by-passed (for example
the C4H-catalyzed step could be by-passed by using
TAL instead of PAL).
Corynebacterium glutamicum
Corynebacterium glutamicum is an important organ-
ism in industrial biotechnology for the microbial
production of bulk chemicals, in particular of amino
acids (Becker and Wittmann 2012). C. glutamicum is
a very robust microorganism, which shows high
resistance to the presence of small aromatic com-
pounds (Liu et al. 2013), which renders C. glutamicum
a very promising host for the production of pharma-
cologically interesting plant-derived polyphenols
(Marienhagen and Bott 2013). Until recently, the
activity of a complex catabolic network for aromatic
compounds meant that C. glutamicum was not used for
the production of aromatic compounds (except for
aromatic amino acids; Shen et al. 2012) due to rapid
degradation of the products of interest. However, C.
glutamicum can be easily modified genetically and a
toolbox for the high-level expression of heterologous
genes originating from other organisms, has become
available, and is based on a set of strong and inducible
promoters (Eggeling and Bott 2005; Pa´tek and
Nesˇvera 2013; Kortmann et al. 2015).
Surprisingly, in initial experiments, it turned out
that C. glutamicum is able to grow on naturally
occurring phenylpropanoids such as p-coumaric acid,
ferulic acid, caffeic acid and 3-(4-hydroxyphenyl)-
propionic acid as sole carbon and energy sources. The
maximum growth rates on the selected phenyl-
propanoids ranged from 0.15 to 0.23 h-1 correspond-
ing to doubling times of 3–4.5 h (Kallscheuer et al.
2016a). We suspected that the activity of this pathway
would come into conflict with any attempt to produce
polyphenols as both pathways compete for phenyl-
propanoids. Unfortunately, the underlying metabolic
pathway responsible for the degradation of phenyl-
propanoids in C. glutamicum was unknown at the start
of the BacHBerry project. Global gene expression
analyses were conducted, which led to the identifica-
tion of a gene cluster consisting of seven genes
(designated phdT, phdA, phdR, phdB, phdC, phdD and
phdE). In response to feeding of the above-mentioned
phenylpropanoids these genes were upregulated up to
100-fold (Kallscheuer et al. 2016a). In subsequent
studies, it turned out that the genes in this cluster code
for the enzymes of the phenylpropanoid catabolic
pathway in C. glutamicum. The gene phdT codes for a
phenylpropanoid transporter protein, whereas phdA
and the predicted operon phdBCDE code for enzymes
involved in the degradation of phenylpropanoids. The
phd gene cluster is transcriptionally controlled by a
MarR-type repressor encoded by phdR. Cultivation
experiments conducted with C. glutamicum strains
carrying single-gene deletions showed that loss of
phdA, phdB, phdC or phdE abolished growth of C.
glutamicum with all tested phenylpropanoid sub-
strates. The intracellular accumulation of pathway
intermediates determined via LC–ESI–MS/MS in
single-gene deletion mutants showed that the phd
gene cluster encodes for enzymes involved in a CoA-
dependent, b-oxidative deacetylation pathway, which
is essential for the utilization of phenylpropanoids in
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C. glutamicum. The identified pathway thereby repre-
sents a peripheral catabolic route responsible for chain
shortening of phenylpropanoids to benzoic acids and
acetyl-CoA (Fig. 7). C. glutamicum converts the
resulting intermediates benzoate, 4-hydroxybenzoate
and protocatechuate to succinyl-CoA and acetyl-CoA
by central degradation pathways for aromatic com-
pounds (especially the well-characterized b-ketoadi-
pate pathway), and catabolites are ultimately
channeled into the tricarboxylic acid cycle (Shen and
Liu 2005; Fig. 7). Unexpectedly, C. glutamicum failed
to grow on the phenylpropanoid, cinnamic acid, which
lacks ring para-hydroxylation. Astonishingly, a C.
glutamicum strain with a single deletion of the gene
phdR coding for the identified transcriptional repressor
was able to grow with cinnamic acid as sole carbon
and energy source (Kallscheuer et al. 2016a). This
indicated that PhdR has a pronounced specificity for
hydroxylated phenylpropanoids, especially when
hydroxylated in para-position of the aromatic ring.
In the course of our studies, cinnamic acid was the
only phenylpropanoid tested lacking this hydroxyla-
tion, so the complete specificity of this catabolic
pathway of phenolics in C. glutamicum remains
unknown.
During construction of the C. glutamicum platform
strain for plant polyphenol production, four gene
clusters, comprising 21 genes, including four genes of
the phd cluster involved in the catabolism of aromatic
compounds, were deleted. The resulting platform
strain C. glutamicum DelAro4 was unable to degrade
any phenylpropanoid tested, and also could not utilize
simple benzoic acids such as protocatechuate
(Kallscheuer et al. 2016c). This strain was used as a
chassis for the microbial production of polyphenols, in
particular, stilbenes and (2S)-flavanones, in C.
glutamicum.
Plasmid-borne expression of codon-optimized
genes coding for a 4CL from parsley (Petroselinum
crispum), a chalcone synthase (CHS) and a chalcone
isomerase (CHI) from Petunia x hybrida from the
strong T7 promoter in this strain background enabled
production of (2S)-flavanones (Fig. 7). Maximal titers
of 35 mg l-1 naringenin and 37 mg l-1 eriodictyol
were obtained from the supplemented phenyl-
propanoids p-coumaric acid and caffeic acid, respec-
tively. Expression of the 4 cl gene in combination with
a codon-optimized gene coding for an STS from
peanut (Arachis hypogaea) allowed for the production
of the stilbenes pinosylvin, trans-resveratrol and
piceatannol starting from supplemented phenyl-
propanoids cinnamic acid, p-coumaric acid and caffeic
acid, respectively (Kallscheuer et al. 2016c; Fig. 7).
Stilbene concentrations of up to 158 mg l-1 could be
achieved in defined CGXII medium with 4% glucose
and supplemented with cerulenin, a fatty-acid biosyn-
thesis inhibitor that is known to enhance polyphenol
production in bacteria by increasing the intracellular
concentrations of malonyl-CoA (Santos et al. 2011;
van Summeren-Wesenhagen and Marienhagen 2015;
Cao et al. 2016). Engineering amino acid metabolism
for an optimal connection to the synthetic plant
polyphenol pathways was conducted to enable stilbene
production directly from glucose. Indeed, the addi-
tional heterologous expression of aroH from E. coli
(coding for the first enzyme of the shikimate pathway
responsible for the synthesis of aromatic amino acids)
together with a codon-optimized gene coding for a
TAL from Flavobacterium johnsoniae led to the
production of up to 60 mg l-1 trans-resveratrol in the
absence of supplemented p-coumaric acid
(Kallscheuer et al. 2016c). Furthermore, C. glutam-
icum was used to produce trans-resveratrol from a
cheaper precursor 4-hydroxybenzoic acid (HBA)
through reversal of a microbial b-oxidative phenyl-
propanoid degradation pathway (Kallscheuer et al.
2016b). This novel synthetic pathway circumvents any
need for the endogenous supply of aromatic amino
acids as polyphenol precursors and in C. glutamicum
instantly yielded 5 mg l-1 trans-resveratrol from
supplemented HBA without any further optimization.
Very recently, we also engineered C. glutamicum to
produce more complex polyphenols including flavo-
nols (kaempferol and quercetin) and O-methylated
stilbenes (pinostilbene and pterostilbene). The
obtained pterostilbene titer was 42 mg l-1, which is
comparable to the titer of 50 mg l-1 obtained in
engineered E. coli. In C. glutamicum, for the flavonols
kaempferol and quercetin titers of 23 and 10 mg l-1,
respectively, were detected. The aforementioned titers
were obtained from the phenylpropanoids p-coumaric
acid and caffeic acid, respectively, as precursors and
represent the highest flavonol titers obtained in
engineered microorganism until today (Kallscheuer
et al. 2017).
The main bottlenecks for the production of
polyphenols turned out to be the TAL activity as well
as the intracellular availability of malonyl-CoA,
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representing the cosubstrate in the STS- and CHS-
reactions. On-going efforts to improve polyphenol
production in C. glutamicum therefore focus mainly
on improving the activity of the rate-limiting enzymes
and increasing the intracellular malonyl-CoA pool.
Other activities
As a part of this work, we also aimed at reconstruction
of a previously unknown biosynthetic pathway for the
flavonol fisetin (3,7,30,40-tetrahydroxyflavone, Fig. 8).
Fisetin is a potent anti-inflammatory, anti-cancer, and
anti-oxidant compound (Suh et al. 2008; Funakoshi-
Tago et al. 2011; Jash and Mondal 2014). Moreover, it
has been demonstrated to have a neuroprotective
effect and also to limit the complications of type I
diabetes (Maher 2009; Maher et al. 2011). Based on
the molecular structure of this compound, we hypoth-
esized that its biosynthesis should follow the general
pathway of flavonol biosynthesis (Figs. 6, 8): a
flavanone precursor would be converted into dihy-
droflavonol by F3H, and then further converted into
the corresponding flavonol via the action of flavonol
synthase (FLS). In the last step of the biosynthesis, a
hydroxyl group would be added at the C30 position by
flavonoid 30-hydroxylase (F30H). This part of the work
was carried out in E. coli. Isoliquiritigenin (20,40,4-
trihydroxychalcone) appeared to be the most suit-
able precursor, and when supplied to an E. coli culture
expressing F3H and FLS from Arabidopsis thaliana,
production of garbanzol and resokaempferol was
detected. Resokaempferol could be further converted
into fisetin by expression of F30H genes from A.
thaliana and Pn. hybrida fused with a cytochrome-
Fig. 7 Overview of the endogenous phenylpropanoid degra-
dation and the engineered pathway for polyphenol synthesis in
C. glutamicum. One of the precursors for the production of the
stilbene trans-resveratrol (catalyzed by stilbene synthase, STS)
or for naringenin chalcone (catalyzed by chalcone synthases,
CHS) is p-coumaroyl-CoA. Naringenin chalcone isomerizes to
the (2S)-flavanone naringenin either spontaneously or catalyzed
by the activity of chalcone isomerase (CHI). In C. glutamicum,
p-coumaric acid can be degraded to 4-hydroxybenzoate by a
CoA-dependent, b-oxidative deacetylation pathway. 4-Hydrox-
ybenzoate is subsequently hydroxylated to protocatechuate,
which is catabolized to succinyl-CoA and acetyl-CoA by the b-
ketoadipate pathway. Genes coding for the underlined enzymes
were deleted in the course of the construction of the platform
strain C. glutamicum DelAro4
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P450 reductase (CPR) from Catharanthus roseus
(Stahlhut et al. 2015). The three enzymes were then
combined with the isoliquiritigenin biosynthetic path-
way, consisting of TAL from Rhodobacter sphaer-
oides, 4CL from Pr. crispum, CHI from Medicago
sativa, and a fusion protein of CHS from Pn. hybrida
and CHR from Astragalus mongholicus, to yield
0.3 mg l-1 of fisetin (Stahlhut et al. 2015). This work
allowed reconstruction of a complete pathway for the
biosynthesis of fisetin from L-tyrosine as the starting
precursor using enzymes from various sources, and the
identified pathway is currently being transferred to
Gram-positive hosts.
Bioinformatics and modelling
There were multiple activities within BacHBerry, both
within the discovery and the microorganism engineer-
ing sectors, which required the use of bioinformatics
tools. Hence, the mathematical modeling and compu-
tational parts of the project aimed at addressing three
major problems. The first two were related to gene
expression, either for performing functional genomics
analysis using the RNA-seq data from berries or to
design sequences for heterologous expression of plant
genes in microbes. The third problem concerned
metabolic network optimization for both a single
population and for a community of microbes. We
detail below the main results obtained on each of the
above activities. Other subjects that were addressed as
a part of this project were metabolic communication
between the different species in a community (Milreu
et al. 2014; Andrade et al. 2016) and modeling
dynamic metabolic networks for potential application
in strain optimization (Costa et al. 2014; Hartmann
et al. 2015a, b, 2016; Costa et al. 2016).
Sequencing data analysis and plant functional
genomics
Understanding which genes are differentially
expressed during phenolic production by plants
requires the capacity to undertake a rapid analysis of
RNA-seq data. One of the main problems to be
addressed in this case is the search for coding
sequences that are homologous to those already
present in sequence databases, which involves iden-
tification, selection and annotation of the best matches.
Currently, such analyses rely heavily on manual
curation as well as on the manual assembly of results
obtained using different computational procedures and
sequence databases. Automated processes become
crucial in the light of the ever-increasing amounts of
generated transcriptome data. Furthermore, automa-
tion of processes also allows improvement of the
quality of the analyses, as the likelihood of human
error grows with the amount of manual processing and
verifications necessary. Moreover, most of the existing
tools are able to annotate the transcriptome but lack
the curation functionalities that are as important as the
primary homology-based identification of candidate
genes.
As mentioned previously we developed a pipeline
called MassBlast (Verı´ssimo et al. 2017), to improve
and accelerate the annotation procedure of RNA-seq
data. Besides allowing for operators to query multiple
databases for performing homology searches, the tool
also provides a set of parameters that can be defined in
a user-friendly way. MassBlast seeks the best align-
ment between the sequences in a dataset consisting of
contigs obtained from RNA-seq assemblies and a
database of known sequences. In the context of
BacHBerry and as a general validation of the method,
MassBlast was used for the analysis of the blackberry
transcriptome, and preliminary results showed a
significant improvement in annotation speed (5 min
vs. at least 26 working days, to annotate all known
CYP families in blackberry) with very high accura-
cies. MassBlast is freely available at https://github.
com/averissimo/mass-blast/.
Sequence design for heterologous expression
Synthetic biology aims at constructing microorgan-
isms capable of producing economically-relevant
chemical products in a cost-effective way, which
involves optimizing the functioning of metabolic
pathways and reactions. These pathways and reactions
involve proteins that are frequently heterologous. In
order to increase the production of metabolites, it is
possible to optimize heterologous protein production
in the target host. This may be done by altering the
codons in the gene that encodes for that protein. Each
codon is a sequence of three nucleotides encoding one
amino acid that is part of a protein. Since each amino
acid can be encoded by several synonymous codons, a
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given protein can be expressed using a large number of
different codon combinations.
To address this problem, we worked on improving
the machine learning models capable of predicting
protein expression levels based on their codon usage
frequency (Fernandes et al. 2016) by using Support
Vector Regression (SVR) and Partial Least Squares
(PLS). SVR yields predictions that surpass those of
PLS. It has been shown that it is possible to improve
the predictive ability of the models by using two
additional input features, namely codon identification
number and codon count, besides the already used
codon bias and minimum free energy. In addition,
applying ensemble averaging to the SVR or the PLS
model improved the results even further. Different
ensembles and features can be tested with the aim of
further improving the prediction models.
Metabolic network optimization
Another goal of the computational activities of
BacHBerry was to explore methods for in silico
metabolic engineering of phenolic production in L.
lactis and C. glutamicum. For this we selected four
model target compounds: fisetin, trans-resveratrol,
pelargonidin and quercetin. Additionally, optimiza-
tion of malonyl-CoA production was also considered,
since this is known to be a major bottleneck in
heterologous flavonoid production. The first step
involved performing network optimization for a single
population, which included prediction of knock-out
strategies and determination of minimal sets of genetic
interventions that could guarantee an increased pro-
duction of the target compound production based on
stoichiometric models for the two organisms. These
predictions were compared with experimental results
and model refinement was conducted in cases of
discrepancies. For the second step, we considered a
use of microbial consortia for production purposes. A
method was developed that is being used for modeling
the production of the compounds of interest for
BacHBerry using L. lactis and C. glutamicum. Other,
possibly larger consortia, may be considered in the
future.
Single strain-based production
Recently, several computational methods for in silico
metabolic network optimization have emerged and are
currently being applied in metabolic engineering
(Vera et al. 2010; Zomorrodi et al. 2012; Machado
et al. 2015; Simeonidis and Price 2015; Bergdahl et al.
2015). They are based on different approaches and
rationales, thereby leading to distinct solutions. One
key issue is the multitude of results, known to be
dependent on the specific algorithms and solvers, used.
In order to address this problem, a consensus-based
approach was developed, following our work on meta-
analysis of transcriptomic studies (Caldas et al. 2014).
This method is based on running several optimization
procedures and analyzing a posteriori the solutions,
looking for a consensus. The rationale is to have
rankings of hypotheses that may provide confidence in
particular sets of proposed genetic alterations from
various aspects.
In the case of a single population of microbes (i.e. a
monoculture), the genome-scale models of L. lactis
and C. glutamicum were extended with the biosyn-
thetic pathways of the four above-mentioned target
compounds (Fig. 9). Subsequently, five different
optimization methods were applied to the genome-
scale models (extended with the heterologous path-
ways): OptKnock (Burgard et al. 2003), MOMA
(Segre` et al. 2002), OptGene (Patil et al. 2005),
RoboKod (Stanford et al. 2015), and RobustKnock
(Tepper and Shlomi 2010), and the consensus ranking
was obtained for each strain and compound. The
hypotheses were generated with the rank product test
and the outputs were lists of gene deletions that would
achieve the best ranks using defined criteria, namely
maximum predicted target compound production,
maximizing the minimum predicted target compound
production and distance from the wild-type flux
distribution. These results were then further filtered
and experimentally validated, resulting in several
promising mutant strains where production was
increased by up to three-fold (unpublished results).
Implementation of this pipeline is possible via a
software package called OptPipe, available at https://
github.com/AndrasHartmann/OptPipe.
We then explored the concept of multi-objective
optimization in the field of metabolic engineering
when both continuous and integer decision variables
were involved in the model. In particular, we proposed
multi-objective models to suggest reaction deletion
strategies and to deal with problems where several
functions must be optimized simultaneously, such as
maximization of bioproducts while minimizing
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toxicity. We thus introduced Multi-Objective Mixed
integer Optimization for metabolic engineering, a
computational framework that aims to model and
solve optimization problems, generated for predicting
reaction knockout strategies by means of multi-
objective programming. We compared the results
from our method with those obtained by using the
well-known bi-level optimization model (OptKnock).
Furthermore, we studied two multi-objective
optimization problems arising from the metabolic
engineering of microorganisms, showing that indeed a
multi-objective setting is promising, as it expands the
set of generated hypotheses and allows inclusion of
multiple goals, simultaneously.
For a community of microbes
Pure microbial cultures have long been used for
production of high-value compounds, as illustrated by
the example of S. cerevisiae producing artemisinic
acid, an important precursor for the anti-malaria drug
artemisinin, on a large scale (Ro et al. 2006; Lenihan
et al. 2008). However, there is increasing evidence that
such processes could run more efficiently if a
community of microbial species is used (Logan and
Rabaey 2012; Jones et al. 2016; Wen et al. 2016).
There are multiple reasons including an increased
production efficiency of the system due to lessening of
metabolic burden for individual cells. Another impor-
tant consideration is that such community systems
might have higher chances of avoiding toxic effects
specific for individual microorganisms. Microbial
consortia are believed to be able to sustain more
complex production pathways, as well as being more
robust as a group. The challenge, however, remains in
establishing precisely which set of strains or species is
best for the production of any given compound.
As part of BacHBerry, we introduced an initial
topological model and a combinatorial algorithm that
enabled us to propose optimal consortia to produce
compounds that were either exogenous to the consor-
tium, or were endogenous but where interaction
between the species in the consortium could improve
the production line (Julien-Laferrie`re et al. 2016). For
initial validations of the model and the method, we
applied it to two case-studies taken from the literature.
The first case involved production of two bioactive
compounds, penicillin and cephalosporin C, both of
which are antibiotics used in the pharma industry. A
synthetic consortium composed of four different
species, three Actinobacteria (Streptomyces cattleya,
Rhodococcus jostii RAH_1 and Rc. erythropolis
BG43) and one methanogenic Archaea (Methanosar-
cina barkeri), was then run through the algorithm,
allowing introduction of genetic manipulations and
regulatory processes. We showed that the best solution
involved only two of the four species, namely St.
cattleya and M. barkeri (Julien-Laferrie`re et al. 2016).
Fig. 8 Heterologous biosynthetic pathway for fisetin assem-
bled in E. coli. TAL tyrosine ammonia-lyase, 4CL 4-coumaroyl-
CoA ligase, CHS::CHR chalcone synthase::chalcone reductase
fusion, CHI chalcone isomerase, F3H flavanone 3-hydroxylase,
FLS flavonol synthase, F30H::CPR flavonoid 30-hydroxylase::-
cytochrome P450 reductase fusion
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Another considered case was a consortium that may be
seen as artificial in the sense that it associates two
wild-type populations of microbes, pathogenic c-
proteobacteria Klebsiella pneumoniae and methano-
genic Archaea M. mazei, which normally do not
interact in nature. K. pneumoniae is a natural producer
of 1,3-propanediol, which is an important building
block for polymer production. Our results demon-
strated that co-cultivation of K. pneumoniae with M.
mazei may enable obtaining higher yields of this
compound in Klebsiella (Julien-Laferrie`re et al. 2016).
This supported a previous study involving co-cultures
of Clostridium sp. with methanogenes such as
Methanosarcina sp. CHTI55 (Koesnandar et al.
1990). The developed algorithms are currently being
used for developing consortia of polyphenol-produc-
ing Gram-positive bacteria. This task was inspired by
the work of Jones and colleagues, who were able to
achieve an overall 970-fold improvement in titers for
flavan-3-ols production from phenylpropanoic acids
by using a co-culture of two E. coli strains with further
optimization of cultivation conditions, as compared to
previous studies that used monocoltures for this
purpose (Jones et al. 2016).
Recovery and purification of polyphenols
from fermentation broth
Downstream processing is an important part of any
production process and consists of steps required for
recovery and purification of biosynthetic products
from fermentation broth, which may have a significant
impact on the final costs of a product (Goldberg 1997).
In the design of downstream processing within
BacHBerry, trans-resveratrol (Fig. 7) was used as
the test product, being one of the model phenolic
compounds that was successfully produced in both C.
glutamicum and L. lactis.
In a typical fermentation broth, most of the
components present are either hydrophilic (e.g., salts,
organic acids, non-consumed carbon sources (usually
glucose), nitrogen source (ammonium sulfate, for
instance)) or are much larger molecules than trans-
resveratrol (e.g., proteins, nucleic acids, cells in
suspension). This suggested a downstream processing
design strategy that used either solubility and
hydrophobicity as the driving forces, or alterna-
tively—size exclusion. Since, at low concentrations
(around 100 mg l-1), crystallization would involve
high energy costs per kg of product recovered, this
Fig. 9 Heterologous
biosynthetic pathways
introduced into the genome-
scale models of C.
glutamicum and L. lactis
leading to the four target
compounds: (i) trans-
resveratrol (ii) pelargonidin
(iii) quercetin and (iv)
fisetin. Two heterologous
enzymes (TAL and 4CL) are
common for the
biosynthesis of the phenolic
molecules. Enzyme
abbreviations: TAL tyrosine
ammonia-lyase, 4CL
4-coumaroyl-CoA ligase,
STS stilbene synthase, CHS
chalcone synthase, CHR
chalcone reductase, CHI
chalcone isomerase, F3H
flavanone 3-hydroxylase,
FLS flavonol synthase, F30H
flavonoid 30 hydroxylase,
CPR cytochrome P450
reductase
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option was discarded. Two possible extraction tech-
niques, namely liquid–liquid extraction and solid–
liquid adsorption, were investigated as means of
recovering and purifying extracellularly produced
trans-resveratrol from a C. glutamicum fermentation
broth containing spent CGXII medium and glucose,
due to the higher production efficiency found in this
bacterium. The downstream process design aimed at a
recovery of at least 80% and a purity of 95% trans-
resveratrol.
Liquid–liquid extraction is a technique to separate a
given compound from a feed solution using an
immiscible auxiliary phase that should be selective
for that compound (Cox and Rydberg 2004). The
logarithm (base 10) of the partition coefficient of
trans-resveratrol between the aqueous and different
potential organic phases was determined experimen-
tally for several different solvents (Fig. 10). The spent
fermentation broth from C. glutamicum was used as
the aqueous phase in these experiments.
All tested organic solvents performed very well in
extracting trans-resveratrol (minimum log P value is
*0.5, corresponding to a partition coefficient of 3.2),
identifying them as suitable candidates for the recov-
ery of this compound (when having different impuri-
ties present; Fig. 10).
One of the drawbacks of using liquid–liquid
extraction, however, is that it may interfere with
protein folding and stability (Prince and Smith 2004).
Besides measuring the partition of the polyphenols of
interest in the aqueous and organic phases, the same
analysis was performed for the total protein content.
Although a considerable part of the total protein
remained in the aqueous phase, some of the protein
seemed to be present in between the two liquid phases
(probably as a result of denaturation and foaming;
Fig. 11). This phenomenon could potentially reduce
the recovery of the desired phenolics, which was also
observed experimentally (data not shown).
Solid–liquid adsorption using hydrophobic resins is
another way of purifying trans-resveratrol. As in
liquid–liquid extraction, the high hydrophobicity of
trans-resveratrol can be used to recover it selectively
from the fermentation broth, leaving the more
hydrophilic impurities behind. After an initial resin
screen, one of the resins selected was the polystyrene-
divinylbenzene based Amberlite XAD-16 from
Sigma-Aldrich (particle diameter: 250–841 lm;
dipole moment: 0.3; surface area: 900 m2 g-1; pore
diameter: 100 A˚).
To test the ability of this resin to recover trans-
resveratrol from C. glutamicum fermentation broth
(containing CGXII spent medium and glucose), a lab-
scale experiment was performed with an AKTA
Explorer chromatographic workstation (GE Health-
care, Sweden; see Fig. 12). A 30 ml column was
packed with resin and pre-equilibrated with MilliQ
water. Afterwards, 10 ml of sample was injected and a
washing step with pure water was performed for 10
column volumes (CV). During elution, a gradient of
water/ethanol was run for about 12 CV and the peak of
trans-resveratrol showed up at around 18 CV, at an
ethanol percentage of 50% (v/v). Regeneration was
performed with 100% ethanol.
More hydrophilic molecules such as organic acids,
sugars and salts appeared in the flow-through (the first
10 CV). During the water/ethanol gradient, molecules
desorbed as a function of their hydrophobicity. More
hydrophobic molecules, such as trans-resveratrol, are
supposed to elute at higher ethanol content in the
mobile phase. In this case, trans-resveratrol appeared
to be the compound eluting between 16 and 20 CV,
since it also showed absorption at 304 nm (Camont
et al. 2009).
Although both liquid–liquid extraction and solid–
liquid adsorption present their own advantages and
disadvantages, a strong point for using adsorption is
the use of ethanol instead of any other organic solvent
that might not be regarded as GRAS. Moreover, not
using liquid–liquid extraction avoids any possible
problems related with protein precipitation and emul-
sification. The ethanol used during elution in adsorp-
tion needs to be recovered from water by distillation
(the azeotrope poses no problem as 80% (v/v) ethanol
can be used).
The proposed downstream process started with a
solid–liquid separation step by centrifugation to
separate biomass from the liquid broth. The clarified
liquid phase was then sent continuously to one of two
adsorption columns, operating staggered in time. The
fraction rich in trans-resveratrol was subsequently
evaporated, resulting in a wet slurry containing the
polyphenol in the solid phase. This slurry was filtered
in a rotary vacuum filter and washed with water to
remove remaining impurities adhered to the surface of
the crystals. The final step was a drying step to obtain
the product in its final solid form. All the outlet
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streams containing ethanol were directed to a distil-
lation column in order to recover the solvent. A make-
up stream ethanol was added to compensate for losses.
Optimization of phenolic production
by fermentation and scale-up of bioprocesses
There are multiple differences between microbial
cultivation in shake flasks versus in bioreactors. The
former lacks monitoring and control of various
parameters, such as dissolved O2 concentration and
pH (Zelle et al. 2010). Furthermore, the fed-batch
fermentation mode, where one or more nutrient is
being supplied throughout cultivation (Moulton
2014), can be done in a controllable and reproducible
fashion only in bioreactors. These properties make
bioreactors a suitable stage for optimization of culti-
vation conditions, often leading to significant
improvements in production yields (Hujanen et al.
2001; Ratnam et al. 2003; Li et al. 2010; Rani and
Appaiah 2011).
From the beginning of the project it was clear that
optimization of fermenter operation would need to be
carried out using a model compound, because any
newly-identified compounds would only be available
at the end of the project. Hence this section of the
project was focused on optimization of production of
the model compound trans-resveratrol. However, it
was expected that the strategies defined and the
conclusions extracted from these results on trans-
resveratrol will be valid for the optimization of the
fermentation processes for the production of other
target compounds. Several L. lactis and C. glutamicum
strains designed within the project were evaluated and
used for fermenter process optimization. The exper-
iments were carried out in agitated 2–5 l fermenters
with automatically–controlled pH, dissolved oxygen
Fig. 10 Partition coefficients in the form of log P values of
trans-resveratrol using different organic solvents using C.
glutamicum fermentation broth as the aqueous phase
Fig. 11 On the left, protein concentration (expressed as
percentage of the initial broth protein concentration) in the
organic and aqueous phases, after performing liquid extraction.
The concentration in the organic phase is almost zero
(considering the error bars), indicating that some protein stayed
in the interphase. On the right, the formation of an interphase
after the broth had been extracted with organic solvent (a
mixture of heptanoic acid and hexyl acetate in this case) was
clear
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and temperature. Whenever required, oxygen was
transferred to the medium by air injection at the
bottom of the vessel.
A major goal of the project was the development of
an economically feasible and sustainable industrial
process, therefore the following key optimization
criteria were defined: (a) minimization of the opera-
tion and investment cost and (b) maximization of the
production rate and operation yield. To achieve these
optimization goals, the following variables have been
investigated: (1) fermentation medium composition,
(2) dissolved oxygen concentration, (3) operation
strategy (batch vs. fed-batch and integrated vs. sepa-
rate downstream operation). Our experiments sug-
gested that there were several constraints limiting the
operation strategy to be implemented, namely: cell
metabolism, the stability of trans-resveratrol inside
the fermenter, and the affinity of trans-resveratrol for
the adsorption medium and solvents compared to other
compounds present in the fermentation broth.
Medium composition is an important parameter
that often has a significant contribution towards the
final production costs. According to our initial exper-
iments, supplementation of C. glutamicum minimal
medium with Brain–Heart Infusion (BHI) and a fatty-
acid biosynthesis inhibitor, cerulenin, had a strong
positive effect on the final titers of trans-resveratrol.
However, removing these two components from the
medium reduced medium costs by approximately
300-fold, resulting in a more than 50-fold drop in
production costs (267 €/g compared to 5 €/g of trans-
resveratrol without supplementation of BHI and
cerulenin).
We also evaluated the feasibility of producing
phenolic compounds from waste materials, namely
cheese whey using L. lactis as a host. Whey is a
lactose-rich dairy industry by-product with a high
environmental impact, if dumped untreated (Palmieri
et al. 2017). To achieve this task, our production strain
was modified to allow it to grow and produce trans-
resveratrol from lactose by introducing a plasmid
carrying the lac operon (Maeda and Gasson 1986).
Production at 2 litre-scale was tested using lactose as
carbon source and comparing the productivity
between the cultures with glucose or lactose. These
experiments demonstrated that the production of
trans-resveratrol from lactose, and therefore from
whey, is possible with slightly inferior productivity
compared to glucose. However, if whey is chosen as
the fermentation medium, other, more important,
issues arise. The cost of whey is comparable to the
cost of glucose but the cost of the fermentation
medium is only a small part of the total production
costs, so variables such as whey availability and
quality, as well as the stability of supply and collecting
logistics will determine the feasibility of the operation
more than the small losses in productivity. Clearly, if a
phenolic production industrial unit were to be imple-
mented inside a dairy company with excess whey, the
whey might then be the best raw material.
Another parameter investigated was the influence
of dissolved oxygen concentration on the production
efficiency of L. lactis. This bacterium can activate its
respiratory chain in the presence of hemin in the
culture medium, and this has been demonstrated to
enhance its survival allowing it to grow to higher cell
densities (Duwat et al. 2001). Therefore the produc-
tion strain efficiency was tested under the following
conditions: aerobic with hemin added to the fermen-
tation broth, aerobic without hemin, semi-aerobic, and
fully anaerobic. In line with the available data, there
was a significant increase in the final biomass when the
strain was grown under aerobic conditions with hemin.
However, the opposite was observed for the produc-
tion of trans-resveratrol where the highest amounts of
the compound were detected under anaerobic
conditions.
Fig. 12 Chromatogram following a pulse injection of 10 ml of
C. glutamicum spent fermentation broth in a 30 ml column
packed with Amberlite XAD-16 resin. A washing step was
performed with 10 column volumes (CVs) of MilliQ water.
Afterwards, elution was performed with a water/ethanol
gradient for 12 CV, followed by a final regeneration step with
100% ethanol
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Lastly, we have also worked on establishing a
system for continuous product removal from the
fermentation broth in order to simplify downstream
processing and reduce trans-resveratrol oxidation due
to prolonged incubation. Two strategies for continu-
ous adsorption and storage of secreted trans-resvera-
trol in a resin have been devised and tested: (1)
‘‘in situ’’ product removal that consisted of adding a
resin directly to the fermentation broth and (2)
‘‘continuous product removal’’ (ConPR) that involved
constant pumping of the fermentation broth through a
column filled with the adsorption resin. The super-
natant was separated from cells via a tangential flow
micro-filtration device, sent though the column, and
then returned back into the fermenter (Fig. 13).
The obtained results demonstrated that both the
‘‘in situ’’ and ConPR strategies lowered the trans-
resveratrol productivity, probably due to co-adsorp-
tion of p-coumaric acid, the precursor for trans-
resveratrol. This effect was most pronounced in the
‘‘in situ’’ operation mode due to continuous contact of
the resin with the supernatant and cells. In the ConPR
operation mode the effect was reduced due to low
supernatant flow rate through the resin, however
adsorption of trans-resveratrol was also reduced. In
contrast, in the ‘‘in situ’’ mode the amount of adsorbed
end-product was nearly identical to the amount of
extracellular and intracellular trans-resveratrol pro-
duced in control experiments without addition of resin.
Although the two techniques did not increase the
overall productivity, they still simplified the down-
stream processing and may lead to a production cost
reduction by eliminating the need to break down the
cells. However, future research may provide a solution
to avoid precursor co-adsorption resulting in increased
polyphenol productivity.
Dissemination, training, societal and ethical issues
In addition to applying the latest technological
advances from life sciences for establishing a pipeline
for microbial-based polyphenol production, BacH-
Berry analyzed the economic potential of the possible
products developed from this research. The assess-
ment of economic issues of the project has been
focused on the market potential of the natural
colorants identified during the screening of the
germplasm collection. This was done along with
obtaining an overview of the relevant regulations and
procedures for approval of novel food additives,
including colorants, in the EU, the United States
(US), and China. Regulations within both the EU and
China confer a strict set of rules for bringing a novel
Fig. 13 Experimental set-up for the ‘‘continuous product removal’’ mode
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Table 5 Summary of the outcomes of the project
Specific
application
area in
project
Bioprospecting for
discovery of novel berry
phenolics
Characterization of
phenolics biosynthetic
pathways
Bacterial cell factories for
production of berry
phenolics
Fermentation and
bioprocess engineering
General aims
of
BacHBerry
To tap into the biodiversity of
berries from around the
globe and of their phenolics
content
Identification and
characterization of berry
phenolics biosynthetic
pathways
Design and generation of
bacterial cell factories for
production of high-value
berry phenolics
Implementation of
production of value-added
phenolics in fermenters up
to demonstration scale
Achievements
of the
project
Standardization of
methodologies for
harvesting, extract
preparation, phenolics
content assessment and
fractionation
Metabolomics data from
berry species originating
from UK, mainland Europe,
Russia, Chile, and China
was obtained and made
available in form of an
online database
Implementation of robust
assays based on the
SMART platform for
discovery of bioactivity and
functionality
Obtained berry extracts were
assayed for bioactivity
against several human
diseases, and additionally
evaluated for other
functional uses (eq. food
additives, antimicrobials).
Bioactivities against
Alzheimer’s, Parkinson’s
and Huntington’s diseases,
Amyotrophic Lateral
Sclerosis and inflammation
were detected
Several pure bioactive
effector compounds were
identified and validated
Transcriptomes of 13
germplasms spanning
eight genera, seven
families and seven
orders were generated
and analyzed
New algorithms for
functional genomics and
improved computational
methods for pathway
identification were
established
Over 4000 candidate
genes for various
biosynthetic steps,
transport and regulation
of polyphenol
production were
identified
Biochemical activities of
some of the gene
candidates were tested,
thus validating the
predictions
Lactococcus lactis strains
were engineered for
stilbene (trans-resveratrol
and pterostilbene) and
anthocyanin production
Production of various
stilbenes (trans-resveratrol,
pinosylvin, and
piceatannol), methylated
stilbenes (pinostilbene and
pterostilbene), flavanones
(naringenin, pinocembrin,
and eryodictiol), and
flavonols (kaempferol and
quercetin) was achieved in
C. glutamicum with yields
comparable to those
obtained in the model
organism E. coli.
Production titers for the
produced flavonols are the
highest titers obtained in
engineered microorganism
until today
Polyphenol production was
further improved by
engineering enhanced
precursor supply (eq. L-
tyrosine, malonyl-CoA) via
rational design, modeling-
based prediction, and use of
biosensors
Alternative biosynthetic
routes were explored
though engineering of
trans-resveratrol
production from
4-hydroxybenzoic acid
(HBA) in C. glutamicum
Computational models were
developed allowing
predicting a minimal set of
modifications needed for
improved polyphenol
production in both a single-
strain population and a
consortium of two or more
species
Cultivation conditions for
improved productivity were
developed for both L. lactis
and C. glutamicum through
optimization of
fermentation parameters
(batch vs. fed-batch
operation, substrate and
dissolved oxygen
concentration, etc.)
Whey was evaluated as an
alternative carbon source
for polyphenol production
in L lactis
Multiple bioseparation
methods for extraction of
produced polyphenols from
fermentation broth were
evaluated
Two possible designs for a
system for continuous
product removal from the
fermentation broth were
implemented
Resveratrol production in C.
glutamicum was scaled up
from shake flask to 5 l
fermenter to demonstration
scale (250 l)
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food colorant, even a natural one, to the market. These
rules consider not only the composition and purity of
the substance, but also the process through which the
compounds have been produced. In contrast, in the
US, a new food additive can gain access to the market
by simply passing the GRAS assessment. Hence, if a
novel polyphenolic colorant could be produced using
engineered microbial cell factories, the US market
should probably be the first market to be targeted,
owing to less strict regulatory requirements for the
approval.
Another topic addressed in BacHBerry was access
and benefit sharing of genetic resources. As the project
was built upon screening of berry species from
multiple countries, including China, Russia, Chile,
Portugal, and the UK, it is important to harness these
resources in a responsible manner. The Nagoya
Protocol on Access to Genetic Resources and the
Fair and Equitable Sharing of Benefits Arising from
their Utilization (NP-ABS) is an agreement consisting
of a set of rules for fair sharing of monetary and non-
monetary benefits arising from the usage and com-
mercialization of genetic resources and traditional
knowledge associated with those. It aims at achieving
fairness and equity of gain distribution, especially
towards indigenous and local communities (SCBD
2011; Morgera et al. 2014). The Protocol came into
force in the EU on June 9th 2014. As most of the
BacHBerry project partners were from EU Member
States, we began collecting information about the best
practices suggested from both the Convention on
Biological Diversity (CBD) and the EU, and kept
monitoring the relevant guidelines and updates from
the EU on implementing ABS. Among the home
countries of the project partners China, Denmark,
France, Germany, Switzerland, and UK ratified or
accepted the NP-ABS (as of November 2016) and
began implementing the aforementioned regulations
(European Parliament 2014). The UK also made its
own regulation on implementing the Protocol (NMRO
(UK) 2015; Secretary of State (UK) 2015).
Funded under the theme of ‘‘Knowledge-based Bio-
Economy’’, a final aim of the project was to provide
scientific and technical solutions to harness berry
resources, as well as to contribute to sustainable
development of the economy. We consequently
investigated the possible contributions of our research
to build a more sustainable society based on environ-
mental, economical, and social impacts (Pei and
Schmidt 2016). Furthermore, we conducted several
open dialog events, namely workshops and interviews
with potential stakeholders from Austria, Denmark,
and China. One of the surprising outcomes was that the
general public raised concerns over the use of
genetically-modified organisms (GMOs) in the pipe-
line a lot less frequently than originally expected. A
free, science-based game for mobile devices called
‘‘Berry Maker’’ was produced (http://www.
berrymaker.com). The game allows the user to fol-
low the pipeline designed within our project, from
acquisition of diverse berries, to extraction and anal-
ysis of biosynthetic genes, to microbial fermentation-
based production of specific polyphenols and running
a biotech factory that is exposed to real world situa-
tions, such as price fluctuations. The game is also
available on iTunes1 and Google Play2 store. Lastly, a
22 min documentary film was produced, showing
sampling of berries, analysis of interesting com-
pounds, and experiments with natural color pigments
for food products from across Europe (see: https://
vimeo.com/193467652).
Conclusions
During 3 years of the project, the BacHBerry partners
successfully established a complete pipeline for
screening, bioprospecting, identification, and micro-
bial production of plant phenolic compounds in Gram-
positive bacteria. A summary of the most important
results is presented in Table 5. The major highlights
are construction of the extensive germplasm collection
database, establishment of a method for high-through-
put screening of bioactive extracts using the yeast-
based human disease models, generation of a vast
berry transcriptome database, construction of micro-
bial cell factories in L. lactis and C. glutamicum for the
production of polyphenols with yields comparable to
those currently available from the literature, release of
several software packages for transcriptome analysis
and in silico-based metabolic engineering, as well as
optimization of fermentation conditions and down-
stream processing for the selected organisms aimed at
1 See: https://itunes.apple.com/us/app/berrymaker-dna-soda-
factory/id1163115116?ls=1&mt=8.
2 See: https://play.google.com/store/apps/details?id=com.
biofaction.berrymaker.
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increasing the yield and the purify of the final
products. The pipeline has been completely validated
and is available to be picked up by the biotech industry
for further improvement and commercialization. The
developed methods and protocols should be suit-
able for discovery, as well as production of most
groups of polyphenols in the above-mentioned organ-
isms, without a need for significant alterations and
adaptations. Overall, this project provided the scien-
tific community with enabling tools and resources to
further advancing research on berries, phenolic com-
pounds, and metabolic engineering of microorgan-
isms. Additional efforts were also focused on
communication with stakeholders, public outreach,
and popularization of science among the younger
generation. The majority of the project outcomes is
already available to the scientific community and the
industry in form of peer-reviewed articles, or will be
published within the coming year.
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